Put companies on watchlist
MEDICLIN AG
ISIN: DE0006595101
WKN: 659510
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MEDICLIN AG · ISIN: DE0006595101 · EQS - Company News (52 News)
Country: Germany · Primary market: Germany · EQS NID: 1894351
02 May 2024 05:14PM

Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May


EQS-News: MEDICLIN AG / Key word(s): Expansion/Contract
MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May

02.05.2024 / 17:14 CET/CEST
The issuer is solely responsible for the content of this announcement.


Offenburg, 2 May 2024

MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May

Offenburg, 2 May 2024: On 1 May, the operation of the Reha-Klinik am Sendesaal was transferred to MEDICLIN.

A symbolic handover of the key between MEDICLIN COO Thomas Piefke, clinic managing director and regional managing director Holger Kammann and Heinz Beekmann, managing director of the Specht Group, took place on Monday. Beekmann presented the "Bremen Key" made of acrylic glass to the MEDICLIN representatives in front of the rehabilitation clinic.

At the beginning of April, representatives of MEDICLIN and the Specht Group signed the purchase agreement for the clinic. The clinic will now operate under the name "MEDICLIN Reha-Klinik am Sendesaal".

"We extend a warm welcome to the employees in Bremen," says MEDICLIN CEO Dr Joachim Ramming. "MEDICLIN has facilities throughout Germany in various areas - rehabilitation, acute care, nursing care, MVZs - but our core competence is and remains rehabilitation."

Piefke adds: "We want to continue to grow in the rehabilitation sector, both inpatient and outpatient. We are delighted that the Reha-Klinik am Sendesaal is now part of the MEDICLIN family!" 

For further information:

MEDICLIN Aktiengesellschaft
Okenstrasse 27
77652 Offenburg
Germany

Investor Relations
Ender Gülcan
Phone: 0781/488-326
ender.guelcan@mediclin.de

Public Relations
Dr Janina Lossen
Phone: 0781/488-180
janina.lossen@mediclin.de

www.mediclin.de


About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group

 


02.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MEDICLIN AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: ender.guelcan@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1894351

 
End of News EQS News Service

1894351  02.05.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1894351&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - MEDICLIN AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.